Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 7, 2011 - Issue 3
Submit an article Journal homepage
1,350
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Could combating vitamin D deficiency reduce the incidence of autoimmune disease?

Brent W Kinder The Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, The University of Cincinnati College of Medicine and the Cincinnati Veteran’s Affairs Medical Center, Cincinnati, OH, USA. [email protected]
&
Jared T Hagaman The Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, The University of Cincinnati College of Medicine and the Cincinnati Veteran’s Affairs Medical Center, Cincinnati, OH, USA
Pages 255-257 | Published online: 10 Jan 2014

References

  • Holick MF. Vitamin D deficiency. N. Engl. J. Med.357(3), 266–281 (2007).
  • van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol.97(1–2), 93–101 (2005).
  • Baeke F, van Etten E, Gysemans C et al. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol. Aspects Med.29(6), 376–387 (2008).
  • Daniel C, Sartory NA, Zahn N et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther.324(1), 23–33 (2008).
  • Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev.29(6), 726–776 (2008).
  • Chen S, Sims GP, Chen XX et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol.179(3), 1634–1647 (2007).
  • Lemire JM, Ince A, Takashima M. 1,25-dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity12(2), 143–148 (1992).
  • Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr.128(1), 68–72 (1998).
  • Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch. Biochem. Biophys.417(1), 77–80 (2003).
  • Cantorna MT, Munsick C, Bemiss C et al. 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr.130(11), 2648–2652 (2000).
  • Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis.66(9), 1137–1142 (2007).
  • Huisman AM, White KP, Algra A et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J. Rheumatol.28(11), 2535–2539 (2001).
  • Kamen DL, Cooper GS, Bouali H et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun. Rev.5(2), 114–117 (2006).
  • Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol.9(6), 599–612 (2010).
  • Becker A, Fischer R, Schneider M. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z. Rheumatol.60(5), 352–358 (2001).
  • Zold E, Szodoray P, Gaal J et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res. Ther.10(5), R123 (2008).
  • Merlino LA, Curtis J, Mikuls TR et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum.50(1), 72–77 (2004).
  • Haque UJ, Bartlett SJ. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin. Exp. Rheumatol.28(5), 745–747 (2010).
  • Zhou C, Assem M, Tay JC et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest.116(6), 1703–1712 (2006).
  • Hagaman JT, Panos RJ, McCormack FX et al. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest139(2), 353–360 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.